Laura Cappelli

24PUBLICATIONS
71CO-AUTHORS
AutoimmunityDiscourse and pragmaticsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 29, 2026
Risk Factors for Immune-Related Adverse Events: Tackling Temporality and Clinical Heterogeneity.

|Jul 15, 2026
Dr. Cappelli et al reply.

|May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.

|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Feb 15, 2024
Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry.

Dimitrios A Pappas, Jacqueline O'Brien, Page C Moore

|Dec 07, 2023
Anti-Peptidylarginine Deiminase 4 Autoantibodies and Disease Duration as Predictors of Treatment Response in Rheumatoid Arthritis.

Laura C Cappelli, David Hines, Hong Wang

Pageof 4

Frequent Collaborators

9 joint publications

Clifton O Bingham

5 joint publications

Jeffrey A Sparks

4 joint publications

Sindhu R Johnson

4 joint publications

Erika Darrah